CSTL1 and colon adenocarcinoma: Promoter methylation levels of 313 colon adenocarcinoma samples and 37 normal tissue samples were analyzed from the TCGA database using the UALCAN platform (Figures 6A–D), indicating that CSTL1 promoter methylation levels in primary malignancies were lower than normal tissue.